See also this year's filing and all EDGAR filings for this company.
PDF Report 0001567514_2023_Intra_Cellular_Therapies_Inc.pdf
Logs
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001567514, Intra-Cellular Therapies Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 737,957,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 1,913,000 |
3 | remainder_Assets | 14,910,000 |
4 | LiabilitiesCurrent | 83,236,000 |
5 | LiabilitiesNoncurrent | 15,474,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 358,782,000 |
9 | ResearchAndDevelopmentExpense | 134,715,000 |
10 | remainder_Expenses | 20,449,000 |
11 | remainder_Revenues | 250,314,000 |
12 | remainder_NetIncome | 7,376,000 |
13 | remainder_ComprehensiveNetIncome | -3,826,000 |
yvar | yval | |
---|---|---|
0 | Assets | 754,780,000 |
1 | Liabilities | 98,710,000 |
2 | Expenses | 513,946,000 |
3 | Revenues | 250,314,000 |
4 | StockholdersEquity | 656,070,000 |
5 | NetIncome | -256,256,000 |
6 | ComprehensiveNetIncome | -258,169,000 |
7 | BaseVar | 814,476,000 |
8 | EconomicCapitalRatio | 2.04 |